Floor and Decor Holdings, Inc. (NYSE: FND)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, has launched an investigation of Floor and Decor Holdings, Inc. (“Floor and Decor”) (NYSE: FND) and several officers and directors for possible violations of federal securities laws.

The firm is investigating potential legal claims against the officers and Board of Directors of Floor and Decor. If you are an affected Floor and Decor shareholder and want to learn more about the investigation, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com, or call toll free at (888) 809-2750. There is no cost or fee to you.

The firm seeks to determine if the defendants violated certain provisions of the Securities Exchange Act of 1934. Specifically, the investigation relates to Floor and Decor and certain of its officers and/or directors have issued materially misleading business information to the investing public. On August 2, 2018, Floor and Decor revealed its 2018 second quarter financial results, reporting a lower than expected revenue and lowering its full year guidance for revenue, comparable-store sales growth, and adjusted earnings per share. On this news, Floor and Decor stock dropped 17%.

The Briscoe Law Firm, PLLC is a full-service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

L3 Technologies, Inc. (NYSE: LLL)

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of L3 Technologies, Inc. (“L3”) (NYSE: LLL) concerning the merger with Harris Corporation (NYSE: HRS).  Under the terms of the agreement, L3 shareholders will only receive 1.30 shares of HRS common stock for each share of L3 stock held.   Based on the closing price of Harris Corporation before the deal was announced, the consideration is virtually no premium over the 52-week high and lower than at least one analyst’s estimated value of $274.00 per share.

If you are an affected investor, and you want to learn more about the investigation or if you have information that you believe would be helpful to our investigation of the fairness of the proposed transaction, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or by calling (888) 809-2750. There is no cost or fee to you.

The investigation centers on whether L3’s Board of Directors is acting in the shareholders’ best interests, whether the board is properly negotiating a higher share price for the shareholders, and whether the board has employed an adequate process to review and act on the proposed transaction.

The Briscoe Law Firm, PLLC is a full-service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation matters, including claims of investor and stockholder fraud, shareholder derivative suits, and securities class actions.

 

Nevro Corp. (NYSE: NVRO)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, announces that a federal class action lawsuit has been filed against Nevro Corp. (“Nevro” or “Company”) (NYSE: NVRO) and several officers and directors for acts taken during the period of January 8, 2018 and July 12, 2018 (the “Class Period”).

Based upon the allegations in the class action, the firm is investigating additional legal claims against the officers and Board of Directors of Nevro.  If you are an affected Nevro shareholder and want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or call toll free at (888) 809-2750.  There is no cost or fee to you.

According to the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934.  Specifically, the complaint alleges, among other things, that on July 10, 2018, analysts reported that a tentative court ruling in patent litigation involving Nevro nullified at least five patents related to the Company’s “proprietary” HF10 pain therapy and Senza delivery systems, which resulted in some analysts downgrading the Company.  Then, on July 13, 2018, the Company disclosed pre-market that it had terminated the employment of James Alecxih, Vice President, Worldwide Sales.  Nevro’s share price plummeted after each of these events, wiping out over $650 million in market capitalization.

The Briscoe Law Firm, PLLC is a full-service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Hortonworks, Inc. (NASDAQ: HDP)

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Hortonworks, Inc. (“Hortonworks”) (NASDAQ: HDP) concerning the sale to Cloudera, Inc. (“Cloudera”) (CLDR). Under the terms of the agreement, Hortonworks shareholders will only receive 1.305 shares of Cloudera common stock for each share owned. Based on the closing price of Cloudera before the deal was announced, the consideration is valued at $21.83 per share, which is virtually no premium over the 52-week high and lower than at least one analyst’s estimated value of $36.00 per share.

If you are an affected investor, and you want to learn more about the investigation or if you have information that you believe would be helpful to our investigation of the fairness of the proposed transaction, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or by calling (888) 809-2750. There is no cost or fee to you.

The investigation centers on whether the Board of Directors of Hortonworks is acting in the shareholders’ best interests, whether the board considered alternatives to the acquisition, and whether the board has employed an adequate process to review and act on the proposed transaction. Notably, at least one analyst with Yahoo! Finance believes the true inherent value of the stock could be as high as $36.00.

The Briscoe Law Firm, PLLC is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Stitch Fix, Inc. (NASDAQ: SFIX)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, has launched an investigation of Stitch Fix, Inc. (“Stitch Fix”) (NASDAQ: SFIX) and several officers and directors for possible violations of federal securities laws.

The firm is investigating potential legal claims against the officers and Board of Directors of Stitch Fix. If you are an affected Stitch Fix shareholder and want to learn more about the investigation, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com, or call toll free at (888) 809-2750. There is no cost or fee to you.

The firm seeks to determine if the Stitch Fix violated certain provisions of the Securities Exchange Act of 1934. The investigation relates to Stitch Fix’s October 1, 2018 announcement of fiscal fourth-quarter earnings ending July 28, 2018, in which it reported lower than expected revenue and weaker-than-expected active client numbers. On this news, the price of Stitch Fix common stock dropped nearly $16 per share, more than 35%, on unusually high trading volume.

The Briscoe Law Firm, PLLC is a full-service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

AbbVie Inc. (NYSE: ABBV)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, announces that a federal class action lawsuit has been filed against AbbVie Inc. (“AbbVie” or “Company”) (NYSE: ABBV) and several officers and directors for acts taken during the period of October 25, 2013 and September 18, 2018 (the “Class Period”).

Based upon the allegations in the class action, the firm is investigating additional legal claims against the officers and Board of Directors of AbbVie. If you are an affected AbbVie shareholder and want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or call toll free at (888) 809-2750. There is no cost or fee to you.

According to the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934. Specifically, the complaint alleges, among other things, that defendants issued false and/or misleading statements and/or failed to disclose the following: (1) AbbVie’s strategy to increase the sales growth of HUMIRA was through illegal kickbacks and unlawful sales and marketing tactics; (2) such practices would lead to heightened scrutiny by State governments and agencies; and (3) as a result, AbbVie’s public statements were materially false and misleading at all relevant times. When this news was revealed to the market, the Company’s stock dropped significantly.

The Briscoe Law Firm, PLLC is a full-service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Pandora Media, Inc. (NYSE: P)

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Pandora Media, Inc. (“Pandora”) (NYSE: P) concerning the sale to Sirius XM Holdings Inc. (SIRI). Under the terms of the agreement, Pandora shareholders will only receive 1.44 Sirius shares for each share owned. Based on the closing price of Sirius stock before the deal was announced, the consideration is valued at approximately $10.14 per share, which is virtually no premium over the 52-week high and lower than at least one analyst’s estimated value of $13.00 per share.

If you are an affected investor, and you want to learn more about the investigation or if you have information that you believe would be helpful to our investigation of the fairness of the proposed transaction, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or by calling (888) 809-2750. There is no cost or fee to you.

The investigation centers on whether Pandora’s Board of Directors is acting in the shareholders’ best interests, whether the board considered alternatives to the acquisition, and whether the board has employed an adequate process to review and act on the proposed transaction. Notably, at least one analyst with Yahoo! Finance believes the true inherent value of the stock could be as high as $13.00.

The Briscoe Law Firm, PLLC is a full-service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.